Xcout Intel
IngateyGen LLC
IngateyGen LLC develops innovative, biofortified peanut varieties with improved safety and nutritional profiles aimed at reducing the risk of peanut allergies. The company partners with the food value chain to deliver these specialized agricultural products to consumers and the market.
Subscribe to see IngateyGen LLC’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
IngateyGen LLC at a glance
IngateyGen LLC is a biotechnology & agriculture company headquartered in United States. It has raised at least $255,000 across the 2 funding rounds on record. Its most recent funding round raised $55,000 in July 2024. Xcout tracks 5 named people at IngateyGen LLC, including Hortense Dodo (Co-Founder and President).
IngateyGen LLC leadership
- Hortense DodoCo-Founder and President
- Koffi KonanCo-Founder and Director of R&D
- Todd AbrahamSenior Vice President of Research and Nutrition
- Hal BurnsManager
- Lee PallesFinancial Advisor
IngateyGen LLC funding rounds
At least $255,000 raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $55,000 | — | |
| Grant | $200,000 | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
IngateyGen LLC competitors
A few of IngateyGen LLC's closest competitors — see the full list of competitors and alternatives →
Ohalo Genetics, Inc. is an agricultural biotechnology company that develops novel breeding systems and improved plant varieties using technologies such as Boosted Breeding and Agile Breeding. The company's technology aims to shorten plant breeding cycles, helping farmers increase crop yields while using fewer natural resources across multiple crops.
Alladapt Immunotherapeutics is a U.S. biotechnology company developing oral immunotherapies for food allergies. Its lead product candidate, ADP101, was designed as a single treatment intended to address multiple food allergies, serving patients with food-allergic disease.
Aimmune Therapeutics is a U.S. biotechnology company focused on treatments for food allergies. Its lead product, Palforzia, is an oral immunotherapy for reducing allergic reactions from accidental peanut exposure in children and adolescents with peanut allergy.
Biothea Pharma, Inc. is a pharmaceutical company developing needle-free, convenient, and cost-effective alternatives for the treatment of severe allergic reactions and anaphylaxis. The company aims to provide improved therapeutic options for patients suffering from life-threatening allergic shocks.
Get IngateyGen LLC's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on IngateyGen LLC in Xcout Intel
- 5 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access